Mechanism of Pingyang Jiangya Formula in treating hypertension based on network pharmacology and in vivo study

Mechanism of Pingyang Jiangya Formula in treating hypertension based on network pharmacology and in vivo study

Objective: This study aimed to analyze the mechanism of action of the Pingyang Jiangya Formula (平阳降压方, PYJYF) in treating hypertension, based on network pharmacology, and to verify the subsequent predictions through animal experiments. Methods: The active components and related target genes of PYJYF...

Full description

Bibliographic Details
Main Authors:	Deguo Liu, Zirong Li, Qihua Chen, Yuhong Wang, Changjiang Xiao
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2021-09-01
Series:	Digital Chinese Medicine
Subjects:	Pingyang Jiangya Formula (平阳降压方, PYJYF) Hypertension Network pharmacology PI3K/Akt signaling pathway Renin-angiotensin-aldosterone system (RAAS) Apoptosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589377721000343

Similar Items

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
by: Natalia Muñoz-Durango, et al.
Published: (2016-06-01)

Hyperkalemia in heart failure patients: current challenges and future prospects
by: López-Vilella R, et al.
Published: (2016-02-01)

The Impact of Vitamin D in the Treatment of Essential Hypertension
by: Christian Legarth, et al.
Published: (2018-02-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
by: Arpacı Abdullah, et al.
Published: (2019-04-01)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
by: Luz Lozano-Maneiro, et al.
Published: (2015-11-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
by: Ramalingam L, et al.
Published: (2020-08-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Renin Feedback Is an Independent Predictor of Outcome in HFpEF
by: Christina Binder, et al.
Published: (2021-05-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)

Mechanical strategies to improve fluid over load in patients with cardiorenal syndrome
by: Murthy
Published: (2013-03-01)

Investigations of Renin-Angiotensin Aldosterone System (RAAS) genes in hypertrophy in hypertrophic cardiomyopathy (HCM) founder families
by: Cloete, Ruben Earl Ashley
Published: (2012)

Qingxuan Jiangya Decoction Reverses Vascular Remodeling by Inducing Vascular Smooth Muscle Cell Apoptosis in Spontaneously Hypertensive Rats
by: Fei Xiao, et al.
Published: (2016-07-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

The effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease
by: Miller, Matthew Scott
Published: (2021)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
by: Simon B. Gressens, et al.
Published: (2021-02-01)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
by: Hau C. Kwaan, et al.
Published: (2021-01-01)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020-11-01)

Beyond the circulating renin angiotensin aldosterone system
by: Walmor eDe Mello
Published: (2014-07-01)

Antihypertensive Effects of <i>Gynura divaricata</i> (L.) DC in Rats with Renovascular Hypertension
by: Mi Hyeon Hong, et al.
Published: (2020-10-01)

Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia
by: Márta Sárközy, et al.
Published: (2018-11-01)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
by: Soo Ji Jeon, et al.
Published: (2020-11-01)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
by: D. B. Adin, et al.
Published: (2021-07-01)

Possibilities ARB II (sartans) in hypertensive patients
by: T E Morozova, et al.
Published: (2014-09-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Renin inhibitors are a new direction in the treatment of arterial hypertension
by: Yuriy Aleksandrovich Vasyuk, et al.
Published: (2010-09-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
by: Zohreh Rahimi, et al.
Published: (2014-01-01)

Protective effects of Zuogui Jiangtang Jieyu Formula on hippocampal neurons in rats of diabetes complicated with depression via the TRP/KYN metabolic pathway
by: Jia, L., et al.
Published: (2022)

The Effect of Sodium Restricted Diet on Plasma Visfatin Levels in Hypertensive Patients with Visceral Obesity
by: Sylwia Rotkegel, et al.
Published: (2013-04-01)

Hyponatremic Hypertensive Syndrome in an Obese Man with Renal Ischemia
by: Saeed Khawer
Published: (2006-01-01)

Susceptibility to hypertensive renal injury mediated by P2X receptors
by: Menzies, Robert Ian
Published: (2014)

The role of the angiotensins in the pathogenesis of inflammatory joint disease
by: Andrei V. Gordeev, et al.
Published: (2021-05-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Changes in plasma aldosterone level after weight loss by bariatric surgery in morbidly obese patients
by: Preaw Suwannasrisuk, et al.
Published: (2020-04-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)